IRIS
GAIDANO, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.205
EU - Europa 18.628
AS - Asia 11.197
SA - Sud America 2.419
AF - Africa 349
Continente sconosciuto - Info sul continente non disponibili 73
OC - Oceania 30
Totale 51.901
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.813
IE - Irlanda 5.567
SG - Singapore 3.869
DE - Germania 2.842
HK - Hong Kong 2.726
SE - Svezia 2.678
UA - Ucraina 2.191
CN - Cina 2.099
BR - Brasile 1.922
IT - Italia 1.492
RU - Federazione Russa 1.479
FI - Finlandia 1.190
VN - Vietnam 1.099
GB - Regno Unito 453
IN - India 371
KR - Corea 317
CA - Canada 220
AR - Argentina 203
FR - Francia 180
ID - Indonesia 125
MX - Messico 123
ZA - Sudafrica 113
BD - Bangladesh 112
BJ - Benin 103
EC - Ecuador 84
NL - Olanda 84
PL - Polonia 83
AT - Austria 74
JP - Giappone 74
EU - Europa 70
IR - Iran 69
ES - Italia 65
TR - Turchia 59
BE - Belgio 55
CZ - Repubblica Ceca 54
IQ - Iraq 52
LT - Lituania 51
CO - Colombia 50
VE - Venezuela 43
PY - Paraguay 42
PK - Pakistan 29
CL - Cile 28
EG - Egitto 28
PE - Perù 27
SY - Repubblica araba siriana 23
MA - Marocco 21
UZ - Uzbekistan 21
KE - Kenya 20
AU - Australia 19
DZ - Algeria 19
SA - Arabia Saudita 16
BG - Bulgaria 15
MY - Malesia 15
RO - Romania 15
IL - Israele 14
DO - Repubblica Dominicana 13
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
TN - Tunisia 12
JO - Giordania 11
KZ - Kazakistan 11
ET - Etiopia 10
AL - Albania 9
CH - Svizzera 9
KG - Kirghizistan 9
NZ - Nuova Zelanda 9
AZ - Azerbaigian 8
NP - Nepal 7
OM - Oman 7
TW - Taiwan 7
HN - Honduras 6
HR - Croazia 6
NG - Nigeria 6
TT - Trinidad e Tobago 6
BH - Bahrain 5
JM - Giamaica 5
LB - Libano 5
RS - Serbia 5
CI - Costa d'Avorio 4
DK - Danimarca 4
GE - Georgia 4
MK - Macedonia 4
NI - Nicaragua 4
AM - Armenia 3
AO - Angola 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
GR - Grecia 3
KW - Kuwait 3
LU - Lussemburgo 3
PA - Panama 3
PH - Filippine 3
PT - Portogallo 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
SR - Suriname 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
Totale 51.864
Salva come PNG Salva come JPEG
Città #
Dublin 5.550
Jacksonville 3.929
Hong Kong 2.723
Dearborn 1.869
Singapore 1.446
Chandler 1.333
Wilmington 1.277
Beijing 997
Ashburn 952
Lawrence 733
Princeton 732
Moscow 609
San Mateo 564
Los Angeles 511
Ho Chi Minh City 398
Andover 379
Piemonte 371
Buffalo 365
Seoul 314
Boardman 313
Ann Arbor 301
Hanoi 231
Houston 201
Woodbridge 199
São Paulo 170
Novara 165
New York 164
Munich 143
Redondo Beach 142
Hefei 135
Dallas 132
Philadelphia 116
Düsseldorf 115
Helsinki 109
Nanjing 109
Cotonou 103
Bremen 102
Kunming 98
Norwalk 91
Grafing 80
Frankfurt am Main 76
Milan 73
Montreal 73
London 67
Tokyo 66
Toronto 66
Warsaw 66
Nuremberg 65
Johannesburg 62
Denver 61
Brooklyn 59
Rio de Janeiro 59
Chennai 58
Mexico City 57
Poplar 57
Santa Clara 55
Seattle 53
Jinan 52
Stockholm 51
Atlanta 50
Brussels 50
Fairfield 50
Haiphong 50
Tianjin 49
Guangzhou 47
Orem 46
Turin 46
Chicago 43
Phoenix 43
Belo Horizonte 42
Curitiba 42
Brno 41
Boston 37
Brasília 37
Da Nang 37
Nanchang 37
Falkenstein 36
Jakarta 36
Rome 36
Vienna 34
Biên Hòa 32
Mumbai 31
Porto Alegre 30
Amsterdam 29
Turku 29
Manchester 28
San Francisco 28
Thái Bình 28
Vercelli 28
Zanjan 28
Guayaquil 27
Dhaka 26
Ninh Bình 25
Quito 25
Ankara 24
Falls Church 24
Shenyang 23
Campinas 21
Fuzhou 21
Salvador 21
Totale 30.864
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 206
Comparative Analysis of the Performance of Automated Digital Cell Morphology Analyzers for Leukocyte Differentiation in Hematologic Malignancies: Mindray MC‐80 Versus West Medical Vision Hema 187
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 178
Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia 160
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 151
Globalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities 144
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 144
Analysis of human beta papillomavirus and Merkel cell polyomavirus infection in skin lesions and eyebrow hair bulbs from a cohort of chronic lymphocytic leukaemia patients. 140
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 139
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 133
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma 132
Benefit sharing and globalisation of industry sponsored clinical trials for breast cancer research 131
The krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 127
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 126
IL LINFOMA PRIMITIVO DELLE SIEROSE E ALTRE MALATTIE LINFOPROLIFERATIVE ASSOCIATE AD HHV-8 125
Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. 124
The clinical implications of gene mutations in chronic lymphocytic leukaemia 124
Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features. 122
6q DELETIONS DEFINE DISTINCT CLINICO-PATHOLOGIC SUBSETS OF NON-HODGKIN'S LYMPHOMA 122
Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment 121
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 116
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 115
A ROLE FOR GROWTH HORMONE AND PROLACTIN IN LEUKAEMIA AND LYMPHOMA? 114
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 114
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 114
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 113
CLINICAL IMPLICATIONS OF THE MOLECULAR GENETICS OF CHRONIC LYMPHOCYTIC LEUKEMIA 113
ANALYSIS OF HUMAN HERPESVIRUS TYPE-8 INFECTION IN AIDS-RELATED AND AIDS-UNRELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA 111
Active AKT signaling triggers CLL towards Richter's transformation via over-activation of Notch1 109
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma 108
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 108
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 107
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 106
MOLECULAR BASES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN LIGHT OF NEW TREATMENTS 106
SIMIAN AIDS-RELATED LYMPHOMA GROWTH IN SCID MICE IS INDEPENDENT OF KARYOTYPIC ABNORMALITIES OR BCL-6 MUTATIONS 105
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 105
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 105
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 105
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 104
Factor VIII as a potential player in cancer pathophysiology 104
AIDS ASSOCIATED LYMPHOMAS ARE EFFICIENTLY LYSED THROUGH COMPLEMENT DEPENDENT CYTOTOXICITY (CDC) AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) BY RITUXIMAB 103
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 103
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 103
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 103
A 2-Mb YAC CONTIG LINKING THE PLASMINOGEN-APOPROTEIN(a) GENE FAMILY TO THE INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR (IGF2R) GENE ON THE TELOMERIC REGION OF CHROMOSOME 6 (6q26-q27) 102
A NEW TAQ I POLYMORPHISM IN THE p53 GENE 102
Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands 102
Recurrent mutations refine prognosis in chronic lymphocytic leukemia. 101
HUMAN NORMAL CD5+ B LYMPHOCYTES CAN BE INDUCED TO DIFFERENTIATE TO CD5- B LYMPHOCYTES WITH GERMINAL CENTER CELL FEATURES 101
ASSOCIATION OF KSHV POSITIVE PRIMARY EFFUSION LYMPHOMA WITH EXPRESSION OF THE CD138/SYNDECAN-1 ANTIGEN 101
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 101
Absence of NOTCH1 gene mutations in MALT lymphomas 101
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial 101
Clues to the pathogenesis of Waldenström Macroglobulinemia and IgM-MGUS provided by the analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors 101
Biology and treatment of Richter syndrome 100
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 100
LINFOMI NON-HODGKIN (NHL) E LINFOMA DI HODGKIN (HD) ASSOCIATI ALL'INFEZIONE DA HIV. CARATTERISTICHE EPIDEMIOLOGICHE, PATOLOGICHE, MOLECOLARI E CLINICHE NELL'ERA DELL'HAART 99
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 99
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders 98
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 98
MOLECULAR INVESTIGATION OF THE CYTOKINES PRODUCED BY NORMAL AND MALIGNANT B LYMPHOCYTES 97
ALTERAZIONI GENETICHE E INTERAZIONI CON IL MICROAMBIENTE NEI LINFOMI MALIGNI 97
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma 97
Extrahepatic sources of factor VIII potentially contribute to the coagulation cascade correcting the bleeding phenotype of mice with hemophilia A 97
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 97
European education corridors: opportunity for academic solidarity 96
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 96
Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of patients with cancer who recovered from SARS-Cov-2 infection: results from the OnCovid registry. 96
SAC I RFLP IN THE INSULIN-LIKE GROWTH FACTOR 2 RECEPTOR GENE (IGF2R) ON HUMAN CHROMOSOME 6q 95
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 95
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 95
The genetics of nodal marginal zone lymphoma 95
MOLECULAR PATHOPHYSIOLOGY OF INDOLENT LYMPHOMA 94
Beta-HPV infection and skin cancer in patients suffering from chronic lymphocytic leukemia. 94
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 94
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment 94
BCL2 MUTATION SPECTRUM IN B-CELL NON-HODGKIN LYMPHOMAS AND PATTERNS ASSOCIATED WITH EVOLUTION OF FOLLICULAR LYMPHOMA 93
ESTABLISHMENT OF AIDS-RELATED LYMPHOMA CELL LINES FROM LYMPHOMATOUS EFFUSIONS 93
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 93
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 93
Targeting p53 in chronic lymphocytic leukemia 93
Chromosome 1 abnormalities in newly diagnosed elderly multiple myeloma patients treated with novel therapies. 92
STRUCTURAL AND FUNCTIONAL ANALYSIS OF ONCOGENES AND TUMOR SUPPRESSOR GENES IN ADULT T-CELL LEUKEMIA/LYMPHOMA SHOWS FREQUENT p53 MUTATIONS 92
HIV-ASSOCIATED HHV-8 POSITIVE PRIMARY LYMPHOMATOUS EFFUSIONS: RADIOLOGICAL FINDINGS IN SIX PATIENTS 92
PATTERNS OF CYTOKINE EXPRESSION IN AIDS-RELATED NON-HODGKIN'S LYMPHOMA 92
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 92
Genetic determinants of response to warfarin. 92
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 92
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study 92
MYC NETWORK MUTATIONS IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKAEMIA 91
KAPOSI's SARCOMA-ASSOCIATED HERPESVIRUS DNA SEQUENCES IN AIDS-RELATED AND AIDS-UNRELATED LYMPHOMATOUS EFFUSIONS 91
Potential of BCL2 as a target for chronic lymphocytic leukemia treatment 91
A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation 91
MOLECULAR PATHOGENESIS OF NON-HODGKIN LYMPHOMA: A CLINICAL PERSPECTIVE 90
EXPRESSION OF MUM-1/IRF4 SELECTIVELY CLUSTERS WITH PRIMARY EFFUSION LYMPHOMA AMONG LYMPHOMATOUS EFFUSIONS. IMPLICATIONS FOR DISEASE HISTOGENESIS AND PATHOGENESIS 90
Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome 89
TAQI RFLP IN THE INTERFERON GAMMA RECEPTOR 1 GENE (IFNGR1) ON HUMAN CHROMOSOME 6q 89
Genetic determinants of response to warfarin. 89
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients 89
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 89
Totale 10.756
Salva come PNG Salva come JPEG
Categoria #
all - tutte 308.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 308.129
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.537 0 0 0 0 0 54 707 33 710 66 826 141
2021/20224.996 122 26 992 587 342 78 488 117 325 140 805 974
2022/202310.113 807 313 461 399 575 833 201 459 5.554 29 298 184
2023/20243.104 241 214 246 76 585 50 630 78 23 41 215 705
2024/20258.283 182 63 257 173 245 473 646 843 2.767 882 332 1.420
2025/202610.681 1.029 893 2.116 3.717 1.947 979 0 0 0 0 0 0
Totale 52.732